Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease

PA Yates, SA Newman, LJ Oshry… - Therapeutic …, 2020 - journals.sagepub.com
Infection with novel SARS-CoV-2 carries significant morbidity and mortality in patients with
pulmonary compromise, such as lung cancer, autoimmune disease, and pneumonia. For …

Sarcoidosis and COVID-19: at the cross-road between immunopathology and clinical manifestation

C Tana, F Cinetto, C Mantini, N Bernardinello, M Tana… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) has been associated with dysregulation of the
immune system featuring inappropriate immune responses, exacerbation of inflammatory …

First report of two cases of löfgren's syndrome after SARS-CoV-2 vaccination-coincidence or causality?

JG Rademacher, B Tampe, P Korsten - Vaccines, 2021 - mdpi.com
Sarcoidosis can present as an acute form or take a chronic course. One of the acute
presentations is Löfgren's syndrome (LS), consisting of the symptom triad of bilateral hilar …

[HTML][HTML] Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire

RP Baughman, EE Lower, M Buchanan… - … Vasculitis, and Diffuse …, 2020 - ncbi.nlm.nih.gov
Background: It has been suggested that sarcoidosis patients, especially those on
immunosuppressive medications, are at increased risk for COVID-19 infection and more …

[HTML][HTML] Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study

YB Hadi, DA Lakhani, SFZ Naqvi, S Singh… - Respiratory Medicine, 2021 - Elsevier
Background Analyses of COVID-19 infection outcomes in patients with preexisting
pulmonary sarcoidosis are lacking and are limited to case reports or small case series with …

COVID-19 and sarcoidosis, readiness for vaccination: challenges and opportunities

M Manansala, A Chopra, RP Baughman… - Frontiers in …, 2021 - frontiersin.org
Sarcoidosis is an immune mediated chronic inflammatory disorder that is best characterized
by non-caseating granulomas found in one or more affected organs. The COVID-19 …

COVID-19 and lung pathologies

D Purohit, AK Ahirwar, A Sakarde, P Asia… - … molecular biology and …, 2021 - degruyter.com
COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths
worldwide. The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. It has …

Corticosteroid use in otolaryngology: current considerations during the COVID-19 era

CWD Chang, ED McCoul, SE Briggs… - … –Head and Neck …, 2022 - journals.sagepub.com
Objective To offer pragmatic, evidence-informed advice on administering corticosteroids in
otolaryngology during the coronavirus disease 2019 (COVID-19) pandemic, considering …

Video consultation during the COVID-19 pandemic: a single center's experience with lung transplant recipients

MZ Kayser, C Valtin, M Greer, B Karow… - Telemedicine and e …, 2021 - liebertpub.com
Background: The coronavirus disease 2019 (COVID-19) pandemic has disrupted health
care systems worldwide. This is due to both to the reallocation of resources toward COVID …

Case series: COVID-19 in African American patients with sarcoidosis

M Manansala, C Ascoli, AG Alburquerque… - Frontiers in …, 2020 - frontiersin.org
Data on the clinical presentation and outcomes of sarcoidosis patients with coronavirus
disease 19 (COVID-19) are scarce. In this case series, we identified 5 out of 238 sarcoidosis …